Qinglian Zhai

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer

Ge Qin, Xin Wang, Shubiao Ye et al. · Nature Communications · 2020 · 176 citations · Full text

Medicine, Molecular Biology, Oncology +15

CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer

Kai Zhang, Ruoxi Hong, Kaping Lee et al. · Cancer Letters · 2019 · 47 citations

Medicine, Oncology, Pharmacology +14

Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer

Qinglian Zhai, Jiawen Fan, Qiulian Lin et al. · PLoS ONE · 2019 · 47 citations · Full text

Medicine, Oncology, Pathology +17

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population

Liye Wang, Qinglian Zhai, Qianyi Lu et al. · Annals of Medicine · 2021 · 31 citations · Full text

Medicine, Genetics, Oncology +15

Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center

Qianyi Lu, Kaping Lee, Fei Xu et al. · Cancer Communications · 2020 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15